EXTELLIA THERAPEUTICS

Welcome to the Brand page for “EXTELLIA THERAPEUTICS”, which is offered here for Pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells based on gene, genome and cellular editing, modulation, modification, engineering, regulation, and repair therapy for use in human therapeutics; diagnostic preparations for medical purposes based on gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy;therapeutics;scientific and medical research in the fields of gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy to develop human pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells for use in human therapeutics and diagnostic products and services; scientific study and research in the fields of gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy to develop human pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells for use in human therapeutics and diagnostic products and services; design of bioinformatic algorithms and models for use in scientific and medical research in the fields of gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy to develop human pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells for use in human therapeutics and diagnostic products and services;.

Its status is currently believed to be active. Its class is unavailable. “EXTELLIA THERAPEUTICS” is believed to be currently owned by “Intellia Therapeutics, Inc.”